Intercure (INCR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.006x

Based on the latest financial reports, Intercure (INCR) has a cash flow conversion efficiency ratio of 0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA2.32 Million ≈ $6.22K USD) by net assets (ILA396.36 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Intercure market cap and net worth for the company's overall valuation and market capitalisation.

Intercure - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Intercure's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intercure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intercure ranked by their cash flow conversion efficiency. Explore earnings quality score of Intercure to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Southland Holdings Inc. NASDAQ:SLND	0.067x
Pappajack Bhd KLSE:0242	-0.045x
New England Realty Associates LP NYSE MKT:NEN	-0.029x
Taita Chemical Co Ltd TW:1309	0.038x
Tumosan Motor ve Traktor Sanayi AS IS:TMSN	0.060x
Hostelworld Group PLC IR:HSW	0.075x
Siljansvik AB (publ) ST:SIVI	0.023x
Frauenthal Holding AG VI:FKA	-0.048x

Annual Cash Flow Conversion Efficiency for Intercure (2010–2025)

The table below shows the annual cash flow conversion efficiency of Intercure from 2010 to 2025. View Intercure share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA396.36 Million ≈ $1.06 Million	ILA16.84 Million ≈ $45.15K	0.042x	+125.25%
2024-12-31	ILA397.67 Million ≈ $1.07 Million	ILA-66.93 Million ≈ $-179.43K	-0.168x	-43.43%
2023-12-31	ILA457.06 Million ≈ $1.23 Million	ILA-53.63 Million ≈ $-143.78K	-0.117x	-219.35%
2022-12-31	ILA521.48 Million ≈ $1.40 Million	ILA51.27 Million ≈ $137.45K	0.098x	+80.43%
2021-12-31	ILA459.19 Million ≈ $1.23 Million	ILA25.02 Million ≈ $67.08K	0.054x	+103.97%
2020-12-31	ILA292.11 Million ≈ $783.13K	ILA7.80 Million ≈ $20.92K	0.027x	+270.54%
2019-12-31	ILA256.20 Million ≈ $686.87K	ILA-4.01 Million ≈ $-10.76K	-0.016x	+79.27%
2018-12-31	ILA19.66 Million ≈ $52.71K	ILA-1.49 Million ≈ $-3.98K	-0.076x	-69.69%
2017-12-31	ILA20.68 Million ≈ $55.44K	ILA-921.03K ≈ $-2.47K	-0.045x	+8.33%
2016-12-31	ILA24.07 Million ≈ $64.53K	ILA-1.17 Million ≈ $-3.14K	-0.049x	+65.72%
2015-12-31	ILA11.95 Million ≈ $32.05K	ILA-1.69 Million ≈ $-4.54K	-0.142x	+94.79%
2014-12-31	ILA697.01K ≈ $1.87K	ILA-1.90 Million ≈ $-5.08K	-2.721x	-220.50%
2013-12-31	ILA3.92 Million ≈ $10.50K	ILA-3.33 Million ≈ $-8.92K	-0.849x	-433.44%
2012-12-31	ILA9.84 Million ≈ $26.37K	ILA-1.57 Million ≈ $-4.20K	-0.159x	-1056.85%
2011-12-31	ILA-51.72 Million ≈ $-138.66K	ILA-860.16K ≈ $-2.31K	0.017x	-93.72%
2010-12-31	ILA-12.03 Million ≈ $-32.26K	ILA-3.19 Million ≈ $-8.54K	0.265x	--

About Intercure

TA:INCR Israel Drug Manufacturers - Specialty & Generic

Market Cap

$254.06 Million

ILA94.77 Billion ILA

Market Cap Rank

#17238 Global

#209 in Israel

Share Price

ILA1600.00

Change (1 day)

-1.84%

52-Week Range

ILA228.00 - ILA1794.00

All Time High

ILA6317.95